In this study, we integrated MD simulations into the deep learning-based drug screening pipeline to identify novel small molecules targeting DNA-PKcs with potent anti-tumor activity, as well as high HDR promotion activity at the expense of NHEJ. The gene discussed is PRKDC; the disease is neoplasm.